Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu G Chen

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Therapeutic Targets for Neurological Diseases|June 23, 2015
The roles of redox enzymes in Parkinson's disease: Focus on glutaredoxinWilliam M Johnson, Amy L Wilson-Delfosse, Shu G Chen, et al.
Journal of Neuroscience Research|January 25, 2008
The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubulesPayal N Gandhi, Xinglong Wang, Xiongwei Zhu, et al.
The Journal of Biological Chemistry|June 26, 2007
FadA from Fusobacterium nucleatum utilizes both secreted and nonsecreted forms for functional oligomerization for attachment and invasion of host cellsMinghua Xu, Mitsunori Yamada, Mei Li, et al.
The Journal of Biological Chemistry|August 15, 2003
Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob diseaseWen-Quan Zou, Sabina Capellari, Piero Parchi, et al.
Experimental Cell Research|August 21, 2007
The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activityLuxuan Guo, Payal N Gandhi, Wen Wang, et al.
Journal of the Neurological Sciences|March 12, 2005
Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's diseaseAli Aliyev, Shu G Chen, Dilara Seyidova, et al.
Experimental Biology and Medicine (Maywood, N.J.)|March 30, 2011
Selection and characterization of DNA aptamers against PrP(Sc)Ping Wang, Kristen L Hatcher, Jason C Bartz, et al.
Alzheimer'S Research & Therapy|October 21, 2021
Gut-microbiota-microglia-brain interactions in Alzheimer's disease: knowledge-based, multi-dimensional characterizationQuanQiu Wang, Pamela B Davis, Xin Qi, et al.
Experimental Biology and Medicine (Maywood, N.J.)|February 1, 2006
DNA aptamers that bind to PrP(C) and not PrP(Sc) show sequence and structure specificityKaori Takemura, Ping Wang, Ina Vorberg, et al.
Molecular Neurodegeneration|December 2, 2006
LRRK2 in Parkinson's disease and dementia with Lewy bodiesXiongwei Zhu, Asim Babar, Sandra L Siedlak, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Therapeutic Targets for Neurological Diseases|June 23, 2015
The roles of redox enzymes in Parkinson's disease: Focus on glutaredoxinWilliam M Johnson, Amy L Wilson-Delfosse, Shu G Chen, et al.
Journal of Neuroscience Research|January 25, 2008
The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubulesPayal N Gandhi, Xinglong Wang, Xiongwei Zhu, et al.
The Journal of Biological Chemistry|June 26, 2007
FadA from Fusobacterium nucleatum utilizes both secreted and nonsecreted forms for functional oligomerization for attachment and invasion of host cellsMinghua Xu, Mitsunori Yamada, Mei Li, et al.
The Journal of Biological Chemistry|August 15, 2003
Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob diseaseWen-Quan Zou, Sabina Capellari, Piero Parchi, et al.
Experimental Cell Research|August 21, 2007
The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activityLuxuan Guo, Payal N Gandhi, Wen Wang, et al.
Journal of the Neurological Sciences|March 12, 2005
Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's diseaseAli Aliyev, Shu G Chen, Dilara Seyidova, et al.
Experimental Biology and Medicine (Maywood, N.J.)|March 30, 2011
Selection and characterization of DNA aptamers against PrP(Sc)Ping Wang, Kristen L Hatcher, Jason C Bartz, et al.
Alzheimer'S Research & Therapy|October 21, 2021
Gut-microbiota-microglia-brain interactions in Alzheimer's disease: knowledge-based, multi-dimensional characterizationQuanQiu Wang, Pamela B Davis, Xin Qi, et al.
Experimental Biology and Medicine (Maywood, N.J.)|February 1, 2006
DNA aptamers that bind to PrP(C) and not PrP(Sc) show sequence and structure specificityKaori Takemura, Ping Wang, Ina Vorberg, et al.
Molecular Neurodegeneration|December 2, 2006
LRRK2 in Parkinson's disease and dementia with Lewy bodiesXiongwei Zhu, Asim Babar, Sandra L Siedlak, et al.
Pageof 6